Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | AMGN | VRTX | REGN | BMY |
| Company | Csl Ltd ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 89.3600 | 309.53 | 419.00 | 959.59 | 43.56 |
| High | 93.2353 | 314.60 | 421.18 | 969.98 | 44.81 |
| Low | 89.3600 | 306.32 | 416.03 | 956.76 | 43.50 |
| Last | 91.7400 | 312.86 | 418.99 | 968.00 | 44.74 |
| Change | -0.0800 | +5.55 | +0.17 | +12.24 | +1.07 |
| % Change | -0.09% | +1.81% | +0.04% | +1.28% | +2.45% |
| Volume | 27,600 | 2,921,300 | 676,100 | 281,900 | 10,776,300 |
| 20-Day Average Volume | 45,045 | 2,907,275 | 1,114,570 | 507,455 | 14,356,360 |
| Previous Close | 91.8200 | 307.31 | 418.82 | 955.76 | 43.67 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 89.9790 | 279.47 | 400.63 | 915.54 | 46.17 |
| 20-Day Raw Stochastic | 70.57% | 84.27% | 80.77% | 96.01% | 22.60% |
| 20-Day Relative Strength | 51.83% | 68.03% | 60.08% | 60.06% | 35.71% |
| Weighted Alpha | -6.03 | +35.65 | +21.42 | +30.41 | -34.69 |
| Today's Opinion | 32% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 32% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 8% Buy | 40% Sell | 24% Buy | 40% Buy | 48% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.76% since 05/02/24 | +12.38% since 05/02/24 | +4.71% since 05/02/24 | +3.24% since 05/02/24 | +2.38% since 05/02/24 |
| Low | 89.3600 on 05/09/24 | 297.52 on 05/06/24 | 394.03 on 05/07/24 | 926.94 on 05/03/24 | 43.49 on 05/09/24 |
| High | 94.1500 on 05/07/24 | 322.60 on 05/03/24 | 425.65 on 05/08/24 | 971.86 on 05/08/24 | 44.81 on 05/09/24 |
| 1-Month | |||||
| %Chg | -1.26% since 04/09/24 | +15.72% since 04/09/24 | +3.59% since 04/09/24 | +2.55% since 04/09/24 | -13.29% since 04/09/24 |
| Low | 85.9600 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 94.3300 on 04/10/24 | 322.60 on 05/03/24 | 425.65 on 05/08/24 | 971.86 on 05/08/24 | 51.28 on 04/10/24 |
| 3-Month | |||||
| %Chg | -7.72% since 02/09/24 | +7.47% since 02/09/24 | -0.93% since 02/09/24 | +1.53% since 02/09/24 | -10.18% since 02/09/24 |
| Low | 85.9600 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 96.9500 on 03/08/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +14.25% since 11/09/23 | +18.48% since 11/09/23 | +13.68% since 11/09/23 | +20.96% since 11/09/23 | -11.25% since 11/09/23 |
| Low | 79.8100 on 11/10/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 99.9500 on 12/27/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 88,744,488 | 164,851,840 | 108,247,808 | 104,906,128 | 88,523,448 |
| Shares Outstanding, K | 966,505 | 536,435 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 13,310,000,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | 2,194,000,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.74 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 09/27/23 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | 0.545 on 03/11/24 | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | 03/11/24 | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.12 | 27.24 | 26.14 | 41.94 |